Literature DB >> 22466318

Reliability of the diagnostic tests for Cushing's syndrome performed in a tertiary referral center.

Mutlu Günes1, Ozlem Celik, Pinar Kadioglu.   

Abstract

The study aimed to retrospectively evaluate the reliability of the diagnostic and location tests in Cushing's Syndrome (CS). Eighty-seven patients diagnosed with CS between 1995 and 2007 by Endocrinology Metabolism Department of Cerrahpasa Medical School were included in the study. The control group consisted of 91 patients who presented to the outpatient clinic because of obesity. The diagnostic tests were as follows: 1 mg dexamethasone suppression test (DST), 24-h urinary free cortisol (UFC), midnight cortisol level (MCL), ACTH level and overnight 8 mg DST. The sensitivity and specificity of UFC were 81 and 66 % respectively for the cut-off point of 50 μg/day, whereas they were 64 and 76 % respectively for the cut-off point of 100 μg/day. For the cut-off value of 1.8/μg/dL for MCL and 1 mDST, the sensitivity rates were 100 and 98 %, while the specificity rates were 88 and 33 %, respectively. Among the location tests, the sensitivity and specificity of ACTH under 10 pg/mL for adrenal CS were 92 and 94 % respectively. The sensitivity and specificity of ACTH higher than 30 pg/mL for ACTH-dependent CS were 69 and 100 % respectively. The sensitivity rates of 8 mg DST for 50 and 60 % suppressions were 83 and 79 % respectively, whereas the specificity rates were 75 and 88 % respectively. 1 mg DST (cut-off <1.8 μg/dL) and UFC (50 μg/24 h) are appropriate tests for screening CS. Overnight 8 mg DST with 60 % suppression for Cushing's Disease (CD) and ACTH levels <10 pg/mL for adrenal CS, ACTH levels >30 pg/mL for ACTH dependency were identified as the best tests for the differential diagnosis of the subtypes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22466318     DOI: 10.1007/s11102-012-0387-7

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  30 in total

1.  Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.

Authors:  M Reincke; J Nieke; G P Krestin; W Saeger; B Allolio; W Winkelmann
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

2.  The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.

Authors:  Francesca Pecori Giraldi; Rosario Pivonello; Alberto Giacinto Ambrogio; Maria Cristina De Martino; Martina De Martin; Massimo Scacchi; Annamaria Colao; Paola Maria Toja; Gaetano Lombardi; Francesco Cavagnini
Journal:  Clin Endocrinol (Oxf)       Date:  2007-02       Impact factor: 3.478

Review 3.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

Authors:  J Newell-Price; P Trainer; M Besser; A Grossman
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

4.  Assessment of ACTH assay variability: a multicenter study.

Authors:  Francesca Pecori Giraldi; Andrea Saccani; Francesco Cavagnini
Journal:  Eur J Endocrinol       Date:  2011-01-20       Impact factor: 6.664

5.  High fluid intake increases urine free cortisol excretion in normal subjects.

Authors:  M V Mericq; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

6.  Clinical laboratory findings and results of therapy in 55 patients with Cushing's syndrome.

Authors:  C Erem; E Algün; N Ozbey; A Azezli; F Aral; Y Orhan; S Molvalilar; E Sencer
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

7.  A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.

Authors:  J Newell-Price; P Trainer; L Perry; J Wass; A Grossman; M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1995-11       Impact factor: 3.478

Review 8.  Cushing's Syndrome.

Authors:  Rosario Pivonello; Maria Cristina De Martino; Monica De Leo; Gaetano Lombardi; Annamaria Colao
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

9.  The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome.

Authors:  L Vilar; M C Freitas; L A Naves; V Canadas; J L Albuquerque; C A Botelho; C S Egito; M J Arruda; L M Silva; C M Arahata; R Agra; L H C Lima; M Azevedo; L A Casulari
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

Review 10.  Laboratory differentiation of Cushing's syndrome.

Authors:  Giuseppe Reimondo; Anna Pia; Silvia Bovio; Barbara Allasino; Fulvia Daffara; Piero Paccotti; Giorgio Borretta; Alberto Angeli; Massimo Terzolo
Journal:  Clin Chim Acta       Date:  2007-11-09       Impact factor: 3.786

View more
  4 in total

1.  Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease.

Authors:  David Asuzu; Grégoire P Chatain; Christina Hayes; Sarah Benzo; Raven McGlotten; Meg Keil; Andrea Beri; Susmeeta T Sharma; Lynnette Nieman; Maya Lodish; Constantine Stratakis; Russell R Lonser; Edward H Oldfield; Prashant Chittiboina
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

2.  Earlier post-operative hypocortisolemia may predict durable remission from Cushing's disease.

Authors:  Natasha Ironside; Gregoire Chatain; David Asuzu; Sarah Benzo; Maya Lodish; Susmeeta Sharma; Lynnette Nieman; Constantine A Stratakis; Russell R Lonser; Prashant Chittiboina
Journal:  Eur J Endocrinol       Date:  2018-01-12       Impact factor: 6.664

3.  Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.

Authors:  David T Asuzu; Reinier Alvarez; Patrick A Fletcher; Debjani Mandal; Kory Johnson; Weiwei Wu; Abdel Elkahloun; Paul Clavijo; Clint Allen; Dragan Maric; Abhik Ray-Chaudhury; Sharika Rajan; Zied Abdullaev; Diana Nwokoye; Kenneth Aldape; Lynnette K Nieman; Constantine Stratakis; Stanko S Stojilkovic; Prashant Chittiboina
Journal:  Cell Rep       Date:  2022-08-23       Impact factor: 9.995

4.  Ectopic ACTH secretion (EAS) associated to a well-differentiated peritoneal mesothelioma: case report.

Authors:  Carmen F Mendoza; Patricia Ontiveros; Daniel X Xibillé; Heriberto Manuel Rivera; Manuel H Rivera
Journal:  BMC Endocr Disord       Date:  2015-08-08       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.